This study introduces Megabouts, a transformer-based classifier for larval zebrafish movement bouts. This useful tool is thoughtfully implemented and has clear potential to unify analyses across labs.

Devout Muslim Amjad Rabbani has already endured one of the longest NHS transplant waits but still has faith of getting that phone call which could transform his life ...

Explore the best gifts for runners we tested and loved. Browse picks from Lululemon, Athleta, ASICS, Supergoop, and more.

The IMvigor010 trial showed that Signatera-guided treatment with Tecentriq improved disease-free survival and overall ...

The bladder cancer treatment landscape is rapidly evolving, particularly for patients who don’t respond to bacillus ...

The experts agreed that perioperative approaches in muscle-invasive bladder cancer continue to evolve. Ongoing data will ...

A rare fish, the Totoaba, faces extinction due to illegal fishing for its valuable swim bladder, called fish maw. This practice also endangers the Vaquita, a marine mammal. The black market for fish ...

SOUTH SAN FRANCISCO, Calif., October 20, 2025--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive results from the Phase III IMvigor011 ...

Florida property tax to be eliminated for seniors under new proposal Shohei Ohtani's Mammoth NLCS Home Run Left Dodgers Teammates in Utter Disbelief Judge rules Tampa’s Walton Academy charter school ...

Innovative medicine is providing hope that treatment of certain breast and bladder cancers will improve. When applied to cases that were found very early and had not spread, the drugs were a cure - ...

Movember is back. Throughout the month of November, men are skipping their razors in favour of sporting a moustache to help ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive results from the Phase III IMvigor011 study evaluating Tecentriq® (atezolizumab) as an adjuvant treatment ...